Associate Principal Scientist AstraZeneca Pharmaceuticals Waltham, Massachusetts
Join AAPS President Annette Bak, Ph.D., MBA, FAAPS and Wenzhan Yang, Ph.D., and several authors in Forum #2 in the Solution Center for a conversation about posters they are especially excited about.
T0930-10-56, An End-to-End Method for AI-Driven Peptide Vaccine Formulation and Translation through Deep Learned Exosome Precision Drug Delivery, Zachary Greenberg, MS, University of Florida, Best Abstract Award and Best Poster Award
T1430-03-18, Application of MicroCoatTM Technology to Mask Bitter Taste of Amodiaquine and Artesunate in a Combination Antimalarial Formulation for Oral Paediatric Administration, Dina Shokry, Ph.D., University of Hertfordshire
M1030-07-38, Development of Lipid Formulation for Oral Delivery of Proteins and Peptides with Poor Permeability, Benoit Holbold, Ph.D., Catalent Pharma Solutions
M1130-01-04, Hydrogel-Forming Microarray Patches Combined with Poly(ethylene)glycol Reservoirs for the Long-Acting Intradermal Deposition of a Poorly-Soluble Drug, Yara A. Naser, Ph.D., Queen’s University Belfast
M1330-12-72, Leveraging Developability Risk Assessment Insights to Identify Key Structural Liabilities and Inform Formulation Strategy for Novel Biologics Modalities, Erik Munsell, Ph.D., Merck & Co., Inc.
T1230-10-57, Potentiating mRNA Delivery through Optimization of Novel Ionizable Lipid Formulations, Diana Kang, BA, Ohio State University
